GSK3B and diabetes mellitus: Under metabolic stress caused by diabetes, abnormal glycogen synthase kinase-3β (GSK-3β) activation could drive tau hypophosphite and β-catenin downregulation, leading to mitochondrial damage and then causing RGC cell apoptosis [5].